Paraneoplastic neurological syndromes can be associated with the presence of onconeural antibodies. These antibodies are the result of an immune response against a tumour that is ectopically expressing a neuronal antigen. The ‘classical’ onconeural antibodies (anti-Hu, Yo, Ma2, CRMP-5, amphiphysin and Ri) are directed against intracellular antigens and are strongly associated with underlying malignancy. By contrast, onconeural antibodies directed against cell surface antigens (eg, anti-NMDA, VGKC, AChR) have a weaker tumour association. This article gives a practical overview of the tumour associations, and the neurological associations, of the onconeural antibodies. There is also guidance on how to investigate occult malignancy in antibody positive cases.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Provenance and peer review Commissioned; externally peer reviewed.
Competing interests None.
Read the full text or download the PDF:
Other content recommended for you
- Republished: Which antibody and which cancer in which paraneoplastic syndromes?
- Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition
- Paraneoplastic neurological syndromes: a practical approach to diagnosis and management
- Rhombencephalomyelitis due to possible paraneoplastic syndrome associated with Hodgkin’s lymphoma
- Opsoclonus-myoclonus paraneoplastic syndrome in nasopharyngeal carcinoma
- A rare case of long-term paraesthesia diagnosed as a paraneoplastic syndrome by anti-SOX1 antibody determination
- Recommended diagnostic criteria for paraneoplastic neurological syndromes
- Protein kinase Cγ autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer
- Delayed onset of a second paraneoplastic neurological syndrome in eight patients
- Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma